[{"address1": "200 Granville Street", "address2": "Suite 2820", "city": "Vancouver", "state": "BC", "zip": "V6C 1S4", "country": "Canada", "phone": "604 336 7906", "website": "https://www.aequuspharma.ca", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Douglas Glen Janzen", "age": 55, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0034, "open": 0.0034, "dayLow": 0.0034, "dayHigh": 0.0034, "regularMarketPreviousClose": 0.0034, "regularMarketOpen": 0.0034, "regularMarketDayLow": 0.0034, "regularMarketDayHigh": 0.0034, "payoutRatio": 0.0, "beta": -0.297, "volume": 10000, "regularMarketVolume": 10000, "averageVolume": 10862, "averageVolume10days": 9543, "averageDailyVolume10Day": 9543, "bid": 0.0034, "ask": 0.004, "bidSize": 55100, "askSize": 100000, "marketCap": 487427, "fiftyTwoWeekLow": 0.0001, "fiftyTwoWeekHigh": 0.015, "priceToSalesTrailing12Months": 0.598045, "fiftyDayAverage": 0.0036486, "twoHundredDayAverage": 0.0040751, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 7052941, "profitMargins": -2.01409, "floatShares": 113163697, "sharesOutstanding": 132634000, "heldPercentInsiders": 0.1468, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 143360992, "bookValue": -0.055, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -1641551, "trailingEps": -0.01, "enterpriseToRevenue": 8.654, "52WeekChange": -0.7733333, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 0.0034, "recommendationKey": "none", "totalCash": 35079, "totalCashPerShare": 0.0, "totalDebt": 6637063, "quickRatio": 0.016, "currentRatio": 0.033, "totalRevenue": 815034, "revenuePerShare": 0.006, "returnOnAssets": -1.03813, "grossProfits": 466415, "freeCashflow": -115996, "operatingCashflow": -443317, "revenueGrowth": 0.352, "grossMargins": 0.57226, "ebitdaMargins": 0.0, "operatingMargins": -0.42071, "financialCurrency": "CAD", "symbol": "AQSZF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1757635200, "exchange": "PNK", "messageBoardId": "finmb_247433914", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Aequus Pharmaceuticals Inc.", "longName": "Aequus Pharmaceuticals Inc.", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0034, "fiftyDayAverageChange": -0.00024860003, "fiftyDayAverageChangePercent": -0.06813573, "twoHundredDayAverageChange": -0.00067510013, "twoHundredDayAverageChangePercent": -0.16566467, "priceToBook": -0.061818182, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1434461400000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.0034 - 0.0034", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 10862, "fiftyTwoWeekLowChange": 0.0033, "fiftyTwoWeekLowChangePercent": 33.0, "fiftyTwoWeekRange": "1.0E-4 - 0.015", "fiftyTwoWeekHighChange": -0.0116, "fiftyTwoWeekHighChangePercent": -0.7733333, "fiftyTwoWeekChangePercent": -77.33333, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.01, "displayName": "Aequus Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]